Mohamed Kharfan-Dabaja: Happy to Share Our Clinical Practice Recommendations in CLL on behalf of ASTCT
Mohamed Kharfan-Dabaja, Vice Chair of Hematology at Mayo Clinic Comprehensive Cancer Center, shared a post on X:
“We are happy to share our recently published clinical practice recommendations on the role of allogeneic hematopoietic cell transplantation and CAR T-cell therapy in chronic lymphocytic leukemia on behalf of ASTCT.”
Title: Clinical practice recommendations on the role of allogeneic hematopoietic cell transplantation and chimeric antigen receptor T-cell therapy in patients with chronic lymphocytic leukemia on behalf of the American Society for Transplantation and Cellular Therapy
Authors: Mohamed A. Kharfan-Dabaja, Ambuj Kumar, Javier Pinilla-Ibarz, Jennifer R. Brown, Mazyar Shadman, Farrukh T. Awan, Saad S. Kenderian, Tanya Siddiqi, Jeremy S. Abramson, Taha Al-Juhaishi, Danielle M. Brander, Catherine C. Coombs, Richard R. Furman, Nitin Jain, Nadia Khan, Nakhle S. Saba, Jennifer M. Collins, Amer Beitinjaneh, Deborah M. Stephens, Jennifer Woyach, Mehdi Hamadani
More Posts featuring Mohamed Kharfan-Dabaja.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023